[Bladder contracture following intravesical BCG immunotherapy treated by hydrodistention: a case report].
A 35-year-old man had undergone retroperitoneoscopic radical nephrouretectomy in May 2002 (pTisNxM0). He later developed carcinoma in situ (CIS) of the bladder, and underwent intravesical instillation of 80 mg of Bacillus-Calmette-Guerin (BCG) once a week for 6 weeks in January 2004. After the treatment, irritative symptoms (frequency and dysuria) developed, and he was diagnosed with bladder contracture. Conventional treatment with anti-cholinergics, analgesics, anti-tuberculous drugs, and steroids was ineffecsive, but hydrodistention improved the subjective symptoms. Hydrodistention seems to be useful for bladder contracture following intravesical BCG immunotherapy.
Department of Urology, Shimada Municipal Hospital.
Atsuro
A
Sawada
Yuusuke
Y
Yagihashi
Norio
N
Kawase
Shigeki
S
Fukuzawa
D000283:Administration, Intravesical; D000328:Adult; D001500:BCG Vaccine / Q000008:administration & dosage / Q000009:adverse effects*; D002278:Carcinoma in Situ / Q000628:therapy; D003286:Contracture / Q000628:therapy*; D004106:Dilatation; D006801:Humans; D006874:Hydrostatic Pressure; D016233:Immunotherapy, Active / Q000009:adverse effects*; D008297:Male; D001743:Urinary Bladder; D001749:Urinary Bladder Neoplasms / Q000628:therapy
D001500:BCG Vaccine